Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	126	61	90	118	149	70
Market Cap Growth	-2.56%	-32.29%	-23.64%	-20.54%	112.60%	-36.02%
Enterprise Value	165	105	131	146	160	74
Last Close Price	1.38	0.68	1.00	1.35	1.70	0.95
PE Ratio	18.72	9.51	13.02	51.35	-	-
PS Ratio	1.45	0.75	1.58	3.30	8.75	27.48
PB Ratio	1.39	0.70	1.13	1.77	2.32	1.83
P/TBV Ratio	1.39	0.70	1.13	1.77	2.32	1.84
P/FCF Ratio	12.85	19.05	-	-	-	-
P/OCF Ratio	8.02	5.73	15.29	-	-	-
EV/Sales Ratio	1.89	1.28	2.29	4.07	9.40	29.09
EV/EBITDA Ratio	11.24	7.62	7.92	16.91	58.11	-
EV/EBIT Ratio	19.69	13.69	11.17	30.25	3041.19	-
EV/FCF Ratio	16.79	32.55	-	-	-	-
Debt / Equity Ratio	0.54	0.55	0.57	0.73	0.33	0.34
Debt / EBITDA Ratio	3.34	3.45	2.75	5.54	7.15	-
Debt / FCF Ratio	4.99	15.04	-	-	-	-
Asset Turnover	0.57	0.55	0.43	0.33	0.23	0.04
Inventory Turnover	1.42	1.41	1.14	1.40	1.39	1.09
Quick Ratio	0.64	0.73	0.70	1.75	1.63	2.32
Current Ratio	2.01	2.50	2.44	3.46	2.82	3.03
Return on Equity (ROE)	7.70%	7.68%	9.48%	3.52%	-2.98%	-29.66%
Return on Assets (ROA)	3.42%	3.23%	5.48%	2.77%	0.04%	-12.16%
Return on Capital (ROIC)	3.88%	3.65%	6.09%	3.01%	0.05%	-13.06%
Return on Capital Employed (ROCE)	6.70%	6.00%	9.70%	4.20%	0.10%	-
Earnings Yield	5.26%	10.52%	7.68%	1.95%	-1.03%	-17.81%
FCF Yield	7.78%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%
Buyback Yield / Dilution	-1.10%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.